Vitamin D: Recent Advances and Implications for Athletes

Sports Medicine

Volumn 45, Issue 2, 2015, Pages 213-229

  Todd, Joshua J ^a   Pourshahidi, L Kirsty ^a   McSorley, Emeir M ^a   Madigan, Sharon M ^b   Magee, Pamela J ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b SPORT IRELAND INSTITUTE   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D;

ADAPTIVE IMMUNITY; ATHLETIC PERFORMANCE; CARDIOVASCULAR FUNCTION; DIET SUPPLEMENTATION; HUMAN; INNATE IMMUNITY; LUNG; PHYSIOLOGY; RESPIRATORY TRACT INFECTIONS; SKELETAL MUSCLE; VITAMIN D DEFICIENCY;

ADAPTIVE IMMUNITY; ATHLETIC PERFORMANCE; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; DIETARY SUPPLEMENTS; HUMANS; IMMUNITY, INNATE; LUNG; MUSCLE, SKELETAL; RESPIRATORY TRACT INFECTIONS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84939576178     PISSN: 01121642     EISSN: 11792035     Source Type: Journal    
DOI: 10.1007/s40279-014-0266-7     Document Type: Review

References (184)

1. Webb AR. Who, what, where and when-influences on cutaneous vitamin D synthesis. Prog Biophys Mol Biol. 2006;92(1):17–25.
2. Ovesen L, Andersen R, Jakobsen J. Geographical differences in vitamin D status, with particular reference to European countries. Proc Nutr Soc. 2003;62(4):813–21.
3. Calvo MS, Whiting SJ, Barton CN. Vitamin D fortification in the United States and Canada: current status and data needs. Am J Clin Nutr. 2004;80(6 Suppl):1710S–6S.
4. Heaney RP, Armas LA, Shary JR, et al. 25-hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. Am J Clin Nutr. 2008;87(6):1738–42.
5. Gallagher JC, Sai AJ. Vitamin D insufficiency, deficiency, and bone health. J Clin Endocrinol Metab. 2010;95(6):2630–3.
6. Wang Y, Zhu J, DeLuca HF. Where is the vitamin D receptor? Arch Biochem Biophys. 2012;523(1):123–33.
7. Lips P. Vitamin D physiology. Prog Biophys Mol Biol. 2006;92(1):4–8.
8. Zhang R, Naughton DP. Vitamin D in health and disease: current perspectives. Nutr J. 2010;9:65.
9. European Food Safety Authority (EFSA). Scientific opinion on the tolerable upper intake level of vitamin D. EFSA J. 2012;10(7):2813.
10. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999;69(5):842–56.
11. Ozkan B, Hatun S, Bereket A. Vitamin D intoxication. Turk J Pediatr. 2012;54(2):93–8.
12. Ahmed MS, Shoker A. Vitamin D metabolites; protective versus toxic properties: molecular and cellular perspectives. Nephrol Rev. 2010;2(1):19–26.
13. Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr. 2008;88(2):582S–6S.
14. Prentice A, Goldberg GR, Schoenmakers I. Vitamin D across the lifecycle: physiology and biomarkers. Am J Clin Nutr. 2008;88(2):500S–6S.
15. Institute of Medicine (IOM). Dietary reference intakes for calcium and vitamin D. Washington DC: The National Academies Press; 2011.
16. Shoenfeld N, Amital H, Shoenfeld Y. The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease. Nat Clin Pract Rheumatol. 2009;5(2):99–105.
17. Mithal A, Wahl DA, Bonjour J, et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int. 2009;20(11):1807–20.
18. Gannage-Yared MH, Maalouf G, Khalife S, et al. Prevalence and predictors of vitamin D inadequacy amongst Lebanese osteoporotic women. Br J Nutr. 2009;101(4):487–91.
19. Diamond TH, Levy S, Smith A, et al. High bone turnover in Muslim women with vitamin D deficiency. Med J Aust. 2002;177(3):139–41.
20. Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72(3):690–3.
21. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004;80(6S):1678S–8S.
22. Marks R. Sunlight and health. BMJ. 1999;319(7216):1066.
23. Matsuoka LY, Ide L, Wortsman J, et al. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab. 1987;64(6):1165–8.
24. Norval M, Wulf HC. Does chronic sunscreen use reduce vitamin D production to insufficient levels? Br J Dermatol. 2009;161(4):732–6.
25. Burnett ME, Wang SQ. Current sunscreen controversies: a critical review. Photodermatol Photoimmunol Photomed. 2011;27(2):58–67.
26. Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab. 1988;67(2):373–8.
27. Huotari A, Herzig KH. Vitamin D and living in northern latitudes—an endemic risk area for vitamin D deficiency. Int J Circumpolar Health. 2008;67(2–3):164–78.
28. MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest. 1985;76(4):1536–8.
29. Vieth R, Ladak Y, Walfish PG. Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J Clin Endocrinol Metab. 2003;88(1):185–91.
30. Engelman CD. Vitamin D recommendations: the saga continues. J Clin Endocrinol Metab. 2011;96(10):3065–6.
31. Pramyothin P, Holick MF. Vitamin D supplementation: guidelines and evidence for subclinical deficiency. Curr Opin Gastroenterol. 2012;28(2):139–50.
32. Pearce SH, Cheetham TD. Diagnosis and management of vitamin D deficiency. BMJ. 2010;11(340):b5664.
33. Heaney RP. Assessing vitamin D status. Curr Opin Clin Nutr Metab Care. 2011;14(5):440–4.
34. Close GL, Fraser WD. Vitamin D supplementation for athletes: too much of a good thing? Sport Exercise Scientist. 2012;33:24–5.
35. Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53–8.
36. Hill KM, Jonnalagadda SS, Albertson AM, et al. Top food sources contributing to vitamin D intake and the association of ready-to-eat cereal and breakfast consumption habits to vitamin D intake in Canadians and United States Americans. J Food Sci. 2012;77(8):170–5.
37. Ogan D, Pritchett K. Vitamin D and the athlete: risks, recommendations, and benefits. Nutrients. 2013;5(6):1856–68.
38. Lovell G. Vitamin D status of females in an elite gymnastics program. Clin J Sport Med. 2008;18(2):159–61.
39. Close GL, Russell J, Cobley JN, et al. Assessment of vitamin D concentration in non-supplemented professional athletes and healthy adults during the winter months in the UK: implications for skeletal muscle function. J Sports Sci. 2013;31(4):344–53.
40. Kopec A, Solarz K, Majda F, et al. An evaluation of the levels of vitamin D and bone turnover markers after the summer and winter periods in Polish professional soccer players. J Hum Kinet. 2013;8(38):135–40.
41. Lanteri P, Lombardi G, Colombini A, et al. Vitamin D in exercise: physiologic and analytical concerns. Clin Chim Acta. 2013;415:45–53.
42. Constantini NW, Arieli R, Chodick G, et al. High prevalence of vitamin D insufficiency in athletes and dancers. Clin J Sport Med. 2010;20(5):368–71.
43. Hamilton B, Grantham J, Racinais S, et al. Vitamin D deficiency is endemic in Middle Eastern sportsmen. Public Health Nutr. 2010;13(10):1528–34.
44. Naeem Z. Vitamin D deficiency—an ignored epidemic. Int J Health Sci. 2010;4(1):V-VI.
45. Lai JK, Lucas RM, Banks E, et al. Variability in vitamin D assays impairs clinical assessment of vitamin D status. Intern Med J. 2012;42(41):43–50.
46. Shah I, James R, Barker J, et al. Misleading measures in vitamin D analysis: a novel LC-MS/MS assay to account for epimers and isobars. Nutr J. 2011;10:46.
47. Wallace AM, Gibson S, de la Hunty A, et al. Measurement of 25-hydroxyvitamin D in the clinical laboratory: current procedures, performance characteristics and limitations. Steroids. 2010;75(7):477–88.
48. Lai JK, Lucas RM, Clements MS, et al. Assessing vitamin D status: pitfalls for the unwary. Mol Nutr Food Res. 2010;54(8):1062–71.
49. Snellman G, Melhus H, Gedeborg R, et al. Determining vitamin D status: a comparison between commercially available assays. PLoS One. 2010;5(7):e11555.
50. Bolek-Berquist J, Elliott ME, Gangnon RE, et al. Use of a questionnaire to assess vitamin D status in young adults. Public Health Nutr. 2009;12(2):236–43.
51. Carter GD. 25-hydroxyvitamin D assays: the quest for accuracy. Clin Chem. 2009;55(7):1300–2.
52. Taylor C, Lamparello B, Kruczek K, et al. Validation of a food frequency questionnaire for determining calcium and vitamin D intake by adolescent girls with anorexia nervosa. J Am Diet Assoc. 2009;109(3):479–85.
53. Hebden L, Kostan E, O’Leary F, et al. Validity and reproducibility of a food frequency questionnaire as a measure of recent dietary intake in young adults. PloS one. 2013;e75156.
54. Chen TC, Shao Q, Heath H, et al. An update on the vitamin D content of fortified milk from the United States and Canada. N Engl J Med. 1993;329(20):1507.
55. Chen TC, Chimeh F, Lu Z, et al. Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem Biophys. 2007;460(2):213–7.
56. Cashman KD, Hill TR, Lucey AJ, et al. Estimation of the dietary requirement for vitamin D in healthy adults. Am J Clin Nutr. 2008;88(6):1535–42.
57. Kulie T, Groff A, Redmer J, et al. Vitamin D: an evidence-based review. J Am Board Fam Med. 2009;22(6):698–706.
58. Christodoulou S, Goula T, Ververidis A, et al. Vitamin D and bone disease. BioMed Res Int. 2013; 396541.
59. Wood RJ, Tchack L, Taparia S. 1,25-dihydroxyvitamin D3 increases the expression of the CaT1 epithelial calcium channel in the caco-2 human intestinal cell line. BMC Physiol. 2001;1:11.
60. Wasserman RH. Vitamin D and the dual processes of intestinal calcium absorption. J Nutr. 2004;134(11):3137–9.
61. Christakos S. Recent advances in our understanding of 1,25-dihydroxyvitamin D(3) regulation of intestinal calcium absorption. Arch Biochem Biophys. 2012;523(1):73–6.
62. Christakos S, Dhawan P, Porta A, et al. Vitamin D and intestinal calcium absorption. Mol Cell Endocrinol. 2011;347(1–2):25–9.
63. Wacker M, Holick MF. Vitamin D - effects on skeletal and extraskeletal health and the need for supplementation. Nutrients. 2013;5(1):111–48.
64. Pasco JA, Henry MJ, Kotowicz MA, et al. Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: the Geelong osteoporosis study. J Bone Miner Res. 2004;19(5):752–8.
65. Villareal DT, Civitelli R, Chines A, et al. Subclinical vitamin D deficiency in postmenopausal women with low vertebral bone mass. J Clin Endocrinol Metab. 1991;72(3):628–34.
66. Holick MF. The role of vitamin D for bone health and fracture prevention. Curr Osteoporos Rep. 2006;4(3):96–102.
67. Wagner CL, Greer FR. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics. 2008;122(5):1142–52.
68. Shaw NJ, Mughal MZ. Vitamin D and child health part 1 (skeletal aspects). Arch Dis Child. 2013;98(5):363–7.
69. Kremer R, Campbell PP, Reinhardt T, et al. Vitamin D status and its relationship to body fat, final height, and peak bone mass in young women. J Clin Endocrinol Metab. 2009;94(1):67–73.
70. Pekkinen M, Viljakainen H, Saarnio E, et al. Vitamin D is a major determinant of bone mineral density at school age. PLoS One. 2012;e40090.
71. Jones BH, Thacker SB, Gilchrist J, et al. Prevention of lower extremity stress fractures in athletes and soldiers: a systematic review. Epidemiol Rev. 2002;24(2):228–47.
72. Iwamoto J, Sato Y, Takeda T, et al. Analysis of stress fractures in athletes based on our clinical experience. World J Orthop. 2011;2(1):7–12.
73. Bennell KL, Malcolm SA, Thomas SA, et al. Risk factors for stress fractures in track and field athletes. A twelve-month prospective study. Am J Sports Med. 1996;24(6):810–8.
74. Haydari M, Rahnama N, Khayambashi K, et al. Association between bone mass and injuries in professional jumpers. Br J Sports Med. 2010;44:i5.
75. Pope CG, Pope HG, Menard W, et al. Clinical features of muscle dysmorphia among males with body dysmorphic disorder. Body Image. 2005;2(4):395–400.
76. Baum A. Eating disorders in the male athlete. Sports Med. 2006;36(1):1–6.
77. Chen YT, Tenforde AS, Fredericson M. Update on stress fractures in female athletes: epidemiology, treatment, and prevention. Curr Rev Musculoskelet Med. 2013;6(2):173–81.
78. Marquez S, Molinero O. Energy availability, menstrual dysfunction and bone health in sports; an overview of the female athlete triad. Nutr Hosp. 2013;28(4):1010–7.
79. Nieves JW, Melsop K, Curtis M, et al. Nutritional factors that influence change in bone density and stress fracture risk among young female cross-country runners. PM R. 2010;2(8):740–50.
80. Lewis RM, Redzic M, Thomas DT. The effects of season-long vitamin D supplementation on collegiate swimmers and divers. Int J Sport Nutr Exerc Metab. 2013;23(5):431–40.
81. Bellows M, Tanguay J, Crouse SF, et al. In: Vitamin D deficiency in TAMU female basketball players and supplement effectiveness. Int J Exerc Sci: Conference proceedings; 2013.
82. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ. 2003;326(7387):469.
83. Winzenberg T, Powell S, Shaw KA, et al. Effects of vitamin D supplementation on bone density in healthy children: systematic review and meta-analysis. BMJ. 2011;342:c7254.
84. Wesner ML. Nutrient effects on stress reaction to bone. Can Fam Physician. 2012;58(11):1226–30.
85. Looker AC, Mussolino ME. Serum 25-hydroxyvitamin D and hip fracture risk in older U.S. white adults. J Bone Miner Res. 2008;23(1):143–50.
86. Thacher TD, Clarke BL. Vitamin D insufficiency. Mayo Clin Proc. 2011;86(1):50–60.
87. Lappe J, Cullen D, Haynatzki G, et al. Calcium and vitamin D supplementation decreases incidence of stress fractures in female navy recruits. J Bone Miner Res. 2008;23(5):741–9.
88. von Domarus C, Brown J, Barvencik F, et al. How much vitamin D do we need for skeletal health? Clin Orthop Relat Res. 2011;469(11):3127–33.
89. Shuler FD, Wingate MK, Moore GH, et al. Sports health benefits of vitamin D. Sports Health. 2012;4(6):496–501.
90. Girgis CM, Clifton-Bligh RJ, Hamrick MW, et al. The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr Rev. 2013;34(1):33–83.
91. Pfeifer M, Begerow B, Minne HW. Vitamin D and muscle function. Osteoporos Int. 2002;13(3):187–94.
92. Willis KS, Peterson NJ, Larson-Meyer DE. Should we be concerned about the vitamin D status of athletes? Int J Sport Nutr Exerc Metab. 2008;18(2):204–24.
93. Rejnmark L. Effects of vitamin D on muscle function and performance: a review of evidence from randomized controlled trials. Ther Adv Chronic Dis. 2011;2(1):25–37.
94. Girgis CM, Clifton-Bligh RJ, Turner N, et al. Effects of vitamin D in skeletal muscle: falls, strength, athletic performance and insulin sensitivity. Clin Endocrinol (Oxf). 2013;80(2):169–81.
95. Ward KA, Das G, Berry JL, et al. Vitamin D status and muscle function in post-menarchal adolescent girls. J Clin Endocrinol Metab. 2009;94(2):559–63.
96. Marantes I, Achenbach SJ, Atkinson EJ, et al. Is vitamin D a determinant of muscle mass and strength? J Bone Miner Res. 2011;26(12):2860–71.
97. Barker T, Henriksen VT, Martins TB, et al. Higher serum 25-hydroxyvitamin D concentrations associate with a faster recovery of skeletal muscle strength after muscular injury. Nutrients. 2013;5(4):1253–75.
98. Barker T, Martins TB, Hill HR, et al. Circulating pro-inflammatory cytokines are elevated and peak power output correlates with 25-hydroxyvitamin D in vitamin D insufficient adults. Eur J Appl Physiol. 2013;113(6):1523–34.
99. Close GL, Leckey J, Patterson M, et al. The effects of vitamin D(3) supplementation on serum total 25[OH]D concentration and physical performance: a randomised dose-response study. Br J Sports Med. 2013;47(11):692–6.
100. Barker T, Martins TB, Hill HR, et al. Vitamin D sufficiency associates with an increase in anti-inflammatory cytokines after intense exercise in humans. Cytokine. 2014;65(2):134–7.
101. Hamilton B, Whiteley R, Farooq A, et al. Vitamin D concentration in 342 professional football players and association with lower limb isokinetic function. J Sci Med Sport. 2014;17(1):139–43.
102. Wyon MA, Koutedakis Y, Wolman R, et al. The influence of winter vitamin D supplementation on muscle function and injury occurrence in elite ballet dancers: a controlled study. J Sci Med Sport. 2014;17(1):8–12.
103. Ceglia L. Vitamin D and skeletal muscle tissue and function. Mol Aspects Med. 2008;29(6):407–14.
104. Haussler MR, Jurutka PW, Mizwicki M, et al. Vitamin D receptor (VDR)-mediated actions of 1alpha,25(OH)(2)vitamin D(3): genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab. 2011;25(4):543–59.
105. Boland R, Norman A, Ritz E, et al. Presence of a 1,25-dihydroxy-vitamin D3 receptor in chick skeletal muscle myoblasts. Biochem Biophys Res Commun. 1985;128(1):305–11.
106. Simpson RU, Thomas GA, Arnold AJ. Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle. J Biol Chem. 1985;260(15):8882–91.
107. Costa EM, Blau HM, Feldman D. 1,25-dihydroxyvitamin D3 receptors and hormonal responses in cloned human skeletal muscle cells. Endocrinology. 1986;119(5):2214–20.
108. Bischoff HA, Borchers M, Gudat F, et al. In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J. 2001;33(1):19–24.
109. Bischoff-Ferrari HA, Borchers M, Gudat F, et al. Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res. 2004;19(2):265–9.
110. Wang Y, Deluca HF. Is the vitamin D receptor found in muscle? Endocrinology. 2011;152(2):354–63.
111. Girgis CM, Mokbel N, Minn Cha K, et al. The vitamin D receptor (VDR) is expressed in skeletal muscle of male mice and modulates 25-hydroxyvitamin D (25OHD) uptake in myofibers. Endocrinology. 2014; Epub ahead of print.
112. de Boland AR, Boland RL. Rapid changes in skeletal muscle calcium uptake induced in vitro by 1,25-dihydroxyvitamin D3 are suppressed by calcium channel blockers. Endocrinology. 1987;120(5):1858–64.
113. Selles J, Boland R. Rapid stimulation of calcium uptake and protein phosphorylation in isolated cardiac muscle by 1,25-dihydroxyvitamin D3. Mol Cell Endocrinol. 1991;77(1–3):67–73.
114. Sato Y, Iwamoto J, Kanoko T, et al. Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc Dis. 2005;20(3):187–92.
115. Girgis CM, Clifton-Bligh RJ, Mokbel N, et al. Vitamin D signaling regulates proliferation, differentiation, and myotube size in C2C12 skeletal muscle cells. Endocrinology. 2014;155(2):347–57.
116. Bhat M, Kalam R, Qadri SS, et al. Vitamin D deficiency-induced muscle wasting occurs through the ubiquitin proteasome pathway and is partially corrected by calcium in male rats. Endocrinology. 2013;154(11):4018–29.
117. Kottler ML. Is vitamin D a key factor in muscle health? Endocrinology. 2013;154(11):3963–4.
118. Foo LH, Zhang Q, Zhu K, et al. Low vitamin D status has an adverse influence on bone mass, bone turnover, and muscle strength in chinese adolescent girls. J Nutr. 2009;139(5):1002–7.
119. Gomez-Alonso C, Naves-Diaz ML, Fernandez-Martin JL, et al. Vitamin D status and secondary hyperparathyroidism: the importance of 25-hydroxyvitamin D cut-off levels. Kidney Int Suppl. 2003;85:S44–8.
120. Miura A, Sato H, Whipp BJ, et al. The effect of glycogen depletion on the curvature constant parameter of the power-duration curve for cycle ergometry. Ergonomics. 2000;43(1):133–41.
121. Jensen MD. Fatty acid oxidation in human skeletal muscle. J Clin Invest. 2002;110(11):1607–9.
122. Smogorzewski M, Piskorska G, Borum PR, et al. Chronic renal failure, parathyroid hormone and fatty acids oxidation in skeletal muscle. Kidney Int. 1988;33(2):555–60.
123. Sinha A, Hollingsworth KG, Ball S, et al. Improving the vitamin D status of vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle. J Clin Endocrinol Metab. 2013;98(3):E509–13.
124. Bouillon R, Verstuyf A. Vitamin D, mitochondria, and muscle. J Clin Endocrinol Metab. 2013;98(3):961–3.
125. Tague SE, Smith PG. Vitamin D receptor and enzyme expression in dorsal root ganglia of adult female rats: modulation by ovarian hormones. J Chem Neuroanat. 2011;41(1):1–12.
126. Dubin AE, Patapoutian A. Nociceptors: the sensors of the pain pathway. J Clin Invest. 2010;120(11):3760–72.
127. Tague SE, Clarke GL, Winter MK, et al. Vitamin D deficiency promotes skeletal muscle hypersensitivity and sensory hyperinnervation. J Neurosci. 2011;31(39):13728–38.
128. Saleh FN, Schirmer H, Sundsfjord J, et al. Parathyroid hormone and left ventricular hypertrophy. Eur Heart J. 2003;24(22):2054–60.
129. McCarty MF. Nutritional modulation of parathyroid hormone secretion may influence risk for left ventricular hypertrophy. Med Hypotheses. 2005;64(5):1015–21.
130. Westerblad H, Allen DG, Lannergren J. Muscle fatigue: lactic acid or inorganic phosphate the major cause? News Physiol Sci. 2002;17:17–21.
131. Gorostiaga EM, Navarro-Amezqueta I, Calbet JA, et al. Energy metabolism during repeated sets of leg press exercise leading to failure or not. PLoS One. 2012;7(7):e40621.
132. van Ballegooijen AJ, Visser M, Cotch MF, et al. Serum vitamin D and parathyroid hormone in relation to cardiac structure and function: the ICELAND-MI substudy of AGES-Reykjavik. J Clin Endocrinol Metab. 2013;98(6):2544–52.
133. Baggish AL, Wood MJ. Athlete’s heart and cardiovascular care of the athlete: scientific and clinical update. Circulation. 2011;123(23):2723–5.
134. Katholi RE, Couri DM. Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications. Int J Hypertens. 2011;2011:495349.
135. Allison RJ, Close GL, Farooq A, et al. Severely vitamin D-deficient athletes present smaller hearts than sufficient athletes. Eur J Prev Cardiol. 2014 (Epub ahead of print).
136. Chinellato I, Piazza M, Sandri M, et al. Vitamin D serum levels and markers of asthma control in Italian children. J Pediatr. 2011;158(3):437–41.
137. Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin D and pulmonary function in the third National Health and Nutrition Examination Survey. Chest. 2005;128(6):3792–8.
138. Rehan VK, Torday JS, Peleg S, et al. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxy vitamin D3: production and biological activity studies in pulmonary alveolar type II cells. Mol Genet Metab. 2002;76(1):46–56.
139. Vedala SR, Paul N, Mane AB. Difference in pulmonary function test among the athletic and sedentary population. Natl J Physiol Pharm Pharmacol. 2013;3(2):118–23.
140. Ardestani A, Parker B, Mathur S, et al. Relation of vitamin D level to maximal oxygen uptake in adults. Am J Cardiol. 2011;107(8):1246–9.
141. Mowry DA, Costello MM, Heelan KA. Association among cardiorespiratory fitness, body fat, and bone marker measurements in healthy young females. J Am Osteopath Assoc. 2009;109(10):534–9.
142. Gregory SM, Parker BA, Capizzi JA, et al. Changes in vitamin D are not associated with changes in cardiorespiratory fitness. Clin Med Res. 2013;2(4):68–72.
143. Forney LA, Earnest CP, Henagan TM, et al. Vitamin D status, body composition, and fitness measures in college-aged students. J Strength Cond Res. 2014;28(3):814–24.
144. Alessio HM, Hagerman AE, Fulkerson BK, et al. Generation of reactive oxygen species after exhaustive aerobic and isometric exercise. Med Sci Sports Exerc. 2000;32(9):1576–81.
145. Gleeson M. Immune function in sport and exercise. J Appl Physiol. 2007;103(2):693–9.
146. Sureda A, Ferrer MD, Tauler P, et al. Effects of exercise intensity on lymphocyte H2O2 production and antioxidant defences in soccer players. Br J Sports Med. 2009;43(3):186–90.
147. Kakanis MW, Peake J, Brenu EW, et al. The open window of susceptibility to infection after acute exercise in healthy young male elite athletes. Exerc Immunol Rev. 2010;16:119–37.
148. Shephard RJ, Shek PN. Effects of exercise and training on natural killer cell counts and cytolytic activity: a meta-analysis. Sports Med. 1999;28(3):177–95.
149. Walsh NP, Gleeson M, Shephard RJ, et al. Position statement. part one: immune function and exercise. Exerc Immunol Rev. 2011;17:6–63.
150. Schleithoff SS, Zittermann A, Tenderich G, et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2006;83(4):754–9.
151. Peterson CA, Heffernan ME. Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25(OH)D concentrations in healthy women. J Inflamm. 2008;24(5):10.
152. Adams JS, Ren S, Liu PT, et al. Vitamin D-directed rheostatic regulation of monocyte antibacterial responses. J Immunol. 2009;182(7):4289–95.
153. Yusupov E, Li-Ng M, Pollack S, et al. Vitamin D and serum cytokines in a randomized clinical trial. Int J Endocrinol. 2010;2010:pii: 305054.
154. Barnes MS, Horigan G, Cashman KD, et al. Maintenance of wintertime vitamin D status with cholecalciferol supplementation is not associated with alterations in serum cytokine concentrations among apparently healthy younger or older adults. J Nutr. 2011;141(3):476–81.
155. Khoo AL, Chai LY, Koenen HJ, et al. Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals. Clin Exp Immunol. 2011;164(1):72–9.
156. Barker T, Martins TB, Hill HR, et al. Different doses of supplemental vitamin D maintain interleukin-5 without altering skeletal muscle strength: a randomized, double-blind, placebo-controlled study in vitamin D sufficient adults. Nutr Metab (Lond). 2012;9(1):16.
157. Willis KS, Smith DT, Broughton KS, et al. Vitamin D status and biomarkers of inflammation in runners. Open Access J Sports Med. 2012;3:35–42.
158. He C, Handzlik M, Fraser WD, et al. Influence of vitamin D status on respiratory infection incidence and immune function during 4 months of winter training in endurance sport athletes. Exerc Immunol Rev. 2013;19:86–101.
159. He C, Fraser WD, Gleeson M. Influence of vitamin D metabolites on plasma cytokine concentrations in endurance sport athletes and on multiantigen stimulated cytokine production by whole blood and peripheral blood mononuclear cell cultures. ISRN Nutr. 2014;2014:820524.
160. van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol. 2005;97(1–2):93–101.
161. Dixon BM, Barker T, McKinnon T, et al. Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults. BMC Res Notes. 2012;24(5):575.
162. Autier P, Boniol M, Pizot C, et al. Vitamin D status and ill health: a systematic review. Lancet Diab Endo. 2014;2(1):76–89.
163. Deluca HF, Cantorna MT. Vitamin D: its role and uses in immunology. FASEB J. 2001;15(14):2579–85.
164. Christakos S, Hewison M, Gardner DG, et al. Vitamin D: beyond bone. Ann N Y Acad Sci. 2013;1287:45–58.
165. Shab-Bidar S, Neyestani TR, Djazayery A, et al. Improvement of vitamin D status resulted in amelioration of biomarkers of systemic inflammation in the subjects with type 2 diabetes. Diabetes Metab Res Rev. 2012;28(5):424–30.
166. Zhang Y, Leung DY, Richers BN, et al. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol. 2012;188(5):2127–35.
167. Larson-Meyer DE, Willis KS. Vitamin D and athletes. Curr Sports Med Rep. 2010;9(4):220–6.
168. Mastorakos G, Pavlatou M, Diamanti-Kandarakis E, et al. Exercise and the stress system. Hormones. 2005;4(2):73–89.
169. Calle MC, Fernandez ML. Effects of resistance training on the inflammatory response. Nutr Res Pract. 2010;4(4):259–69.
170. Cantorna MT, Zhu Y, Froicu M, et al. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr. 2004;80(6 Suppl):1717S–20S.
171. Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am. 2010;39(2):365–79.
172. Jeffery LE, Wood AM, Qureshi OS, et al. Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses. J Immunol. 2012;189(11):5155–64.
173. Hewison M, Freeman L, Hughes SV, et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol. 2003;170(11):5382–90.
174. Prietl B, Pilz S, Wolf M, et al. Vitamin D supplementation and regulatory T cells in apparently healthy subjects: vitamin D treatment for autoimmune diseases? Isr Med Assoc J. 2010;12(3):136–9.
175. Bock G, Prietl B, Mader JK, et al. The effect of vitamin D supplementation on peripheral regulatory T cells and beta cell function in healthy humans: a randomized controlled trial. Diabetes Metab Res Rev. 2011;27(8):942–5.
176. Peterson RA. Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression. Toxicol Pathol. 2012;40(2):186–204.
177. Spence L, Brown WJ, Pyne DB, et al. Incidence, etiology, and symptomatology of upper respiratory illness in elite athletes. Med Sci Sports Exerc. 2007;39(4):577–86.
178. White JH. Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect Immun. 2008;76(9):3837–43.
179. Di Nardo A, Vitiello A, Gallo RL. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol. 2003;170(5):2274–8.
180. Guo C, Sinnott B, Niu B, et al. Synergistic induction of human cathelicidin antimicrobial peptide gene expression by vitamin D and stilbenoids. Mol Nutr Food Res. 2014;58(3):528–36.
181. Vandamme D, Landuyt B, Luyten W, et al. A comprehensive summary of LL-37, the factotum human cathelicidin peptide. Cell Immunol. 2012;280(1):22–35.
182. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311(5768):1770–3.
183. Shirakawa AK, Nagakubo D, Hieshima K, et al. 1,25-dihydroxyvitamin D3 induces CCR10 expression in terminally differentiating human B cells. J Immunol. 2008;180(5):2786–95.
184. Xiong N, Fu Y, Hu S, et al. CCR10 and its ligands in regulation of epithelial immunity and diseases. Protein Cell. 2012;3(8):571–80.